Increased CSF PCSK9 is also correlated with specific AD biomarkers including amyloid β (Aβ42), phospho Tau (P-tau), and total Tau (T-tau) (Zimetti et al., 2017; Picard et al., 2019). Here, PCSK9 is linked to Alzheimer disease.